Company: BAYAU
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001641172-25-002125
Chunk: 1311

Company: Bayview Acquisition Corp
Filing Date: 2025-04-01
Form: 10-K
Item: Item 15
Chunk 1311
---
 the year ended December
                                                                                31,
                                            2024  
    For
                                            the period from February  16,
                                            2023 (inception) to  December
                                            31, 2023 

    Redeemable  
    Non-
    Redeemable  
    Redeemable  
    Non-
    Redeemable 

    Shares  
    Shares  
    Shares  
    Shares 
  
    Basic and diluted net income
    (loss) per share: 

    Numerators: 

    Allocation of
    net loss including accretion of temporary equity 
    $(1,153,705) 
    $(372,461) 
    $(951,427) 
    $(5,693,439)
  
    Income earned on investment
    held in Trust Account 
     2,779,141  
     -  
     107,055  
     - 
  
    Accretion
    of temporary equity to redemption value (extension deposit) 
     500,000  
     -  
     6,623,327  
     - 
  
    Allocation
    of net income (loss) 
    $2,125,436  
    $(372,461) 
    $5,778,955  
    $ (5,693,439 )

    Denominators: 

    Weighted-average
    shares outstanding 
     5,417,863  
     1,749,098  
     244,514  
     1,463,197 
  
    Basic
    and diluted net income (loss) per share 
    $0.39  
    $(0.21) 
    $23.63  
    $(3.89)

Concentration
of Credit Risk

Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.

     F-11 

Fair
Value of Financial Instruments

The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value
Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short